CIK 0001761612
- Non-accelerated filer
- Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 8,800 shares (grant or award)
- 4 Open-market buy Director bought 1,485,397 shares at an average $14.29 ($21,230,385)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 6,256 shares at an average $25.11 ($157,114)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 3,212 shares at $22.26 ($71,499)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 247 shares at $22.26 ($5,498)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 972 shares at $22.26 ($21,637)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 972 shares at $22.26 ($21,637)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 972 shares at $22.26 ($21,637)
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 153 shares at $22.26 ($3,406)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 246 shares at $19.64 ($4,831)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 967 shares at $19.64 ($18,992)
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 148 shares at $19.64 ($2,907)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 967 shares at $19.64 ($18,992)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 779 shares at $19.64 ($15,300)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 3,194 shares at $19.64 ($62,730)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 967 shares at $19.64 ($18,992)
- 4 Conversion Director acquired 2,382,784 shares (conversion)
- 4 Derivatives Options or other derivatives
Page 5 of 16 · 304 filings